Literature DB >> 10933595

Fidelity and infidelity in commitment to B-lymphocyte lineage development.

A G Rolink1, C Schaniel, M Busslinger, S L Nutt, F Melchers.   

Abstract

During B-lymphocyte development in mouse fetal liver and bone marrow, a pre-B I cell stage is reached in which the cells express B-lineage-specific genes, such as CD19, Ig alpha and Igbeta and VpreB and lambda5, which encode the surrogate light (SL) chain. In these pre-B I cells both alleles of the immunoglobulin heavy (IgH) chain locus are D(H)J(H) rearranged. Transplantation of pre-B I cells from wild-type (e.g. C57Bl/6) mice in histocompatible RAG-deficient hosts leads to long-term reconstitution of some of the mature B-cell compartments and to the establishment of normal IgM levels, a third of the normal serum IgA levels, and IgG levels below the detection limit. Neither T-lineage nor myeloid cells of donor origin can be detected in the transplanted hosts, indicating that the pre-B I cells are committed to B-lineage differentiation. Consequently, the B-cell-reconstituted hosts respond to T-cell-independent antigens but not to T-cell-dependent antigens. Responses to T-cell-dependent antigens can be restored in the pre-B I-cell-transplanted, RAG-deficient hosts by the concomitant transplantation of mature CD4+ T cells. The transplanted wild-type pre-B I cells do not home back to the bone marrow and become undetectable shortly after transplantation. B-lymphocyte development in Pax-5-deficient mice becomes arrested at the transition of pre-B I to pre-B II cells i.e. at the stage when V(H) to D(H)J(H) rearrangements occur and when the pre-B-cell receptor, complete with muH chains and SL chains, is normally formed. T-lineage and myeloid cell development in these mice is normal. Pre-B I cells of Pax-5-deficient mice have a wild-type pre-B I-cell-like phenotype: while they do not express Pax-5-controlled CD19 gene, and express Ig alpha to a lesser extent, they express Igbeta, VpreB and lambda5, and proliferate normally in vitro on stromal cells in the presence of interleukin (IL)-7. Clones of these pre-B I cells carry characteristic D(H)J(H) rearrangements on both IgH chain alleles. However, removal of IL-7 from the tissue cultures, unlike wild-type pre-B I cells, does not induce B-cell differentiation to surface IgM-expressing B cells, but induces macrophage differentiation. This differentiation into macrophages requires either the presence of stromal cells or addition of macrophage colony-stimulating factor (M-CSF). Addition of M-CSF followed by granulocyte-macrophage colony-stimulating factor induces the differentiation to MHC class II-expressing, antigen-presenting dendritic cells. In vitro differentiation to granulocytes and osteoclasts can also be observed in the presence of the appropriate cytokines. Moreover, transplantation of Pax-5-deficient pre-B I clones into RAG-deficient hosts, while not allowing B-cell differentiation, leads to the full reconstitution of the thymus with all stages of CD4-CD8- and CD4+CD8+ thymocytes, to normal positive and negative selection of thymocytes in the thymus, and to the development of normal, reactive mature CD4+ and CD8+ T-cell compartments in the peripheral lymphoid tissues, all carrying the clone-specific D(H)J(H) rearrangements. On the other hand, Ig alpha, Igbeta, VpreB and lambda5 are turned off in the thymocytes, demonstrating that the expression of these genes does not commit cells irreversibly to the B lineage. Further more, Pax-5-deficient pre-B I cells are long-term reconstituting cells. They home back to the bone marrow of the RAG-deficient host, can be reisolated and regrown in tissue culture, and can be retransplanted into a secondary RAG-deficient host. This again develops thymocytes and mature T cells and allows the transplanted clonal pre-B I cells to home to the bone marrow.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933595

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  22 in total

1.  The new stem cell biology.

Authors:  Peter J Quesenberry; Gerald A Colvin; Jean-Francois Lambert; Angela E Frimberger; Mark S Dooner; Christina I Mcauliffe; Caroline Miller; Pamela Becker; Evangelis Badiavas; Vincent J Falanga; Gerald Elfenbein; Lawrence G Lum
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

Review 2.  A developing picture of lymphopoiesis in bone marrow.

Authors:  Jun Hirose; Taku Kouro; Hideya Igarashi; Takafumi Yokota; Nobuo Sakaguchi; Paul W Kincade
Journal:  Immunol Rev       Date:  2002-11       Impact factor: 12.988

3.  Antibody repertoire development in fetal and neonatal piglets. XXII. λ Rearrangement precedes κ rearrangement during B-cell lymphogenesis in swine.

Authors:  Xiuzhu Sun; Nancy Wertz; Kelly Lager; Marek Sinkora; Katerina Stepanova; Gregory Tobin; John E Butler
Journal:  Immunology       Date:  2012-10       Impact factor: 7.397

4.  Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4.

Authors:  Yong-Hao Hou; Edward F Srour; Heather Ramsey; Richard Dahl; Hal E Broxmeyer; Robert Hromas
Journal:  Blood       Date:  2005-01-13       Impact factor: 22.113

5.  Alcohol affects the late differentiation of progenitor B cells.

Authors:  Hao Wang; Huijuan Zhou; Simon Mahler; Robert Chervenak; Michael Wolcott
Journal:  Alcohol Alcohol       Date:  2010-11-22       Impact factor: 2.826

Review 6.  [From stem cells to lymphocytes].

Authors:  F Melchers
Journal:  Z Rheumatol       Date:  2009-05       Impact factor: 1.372

Review 7.  Impaired B lymphopoiesis in old age: a role for inflammatory B cells?

Authors:  Richard L Riley
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 8.  Checkpoints that control B cell development.

Authors:  Fritz Melchers
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

9.  Pax-5 Inhibits NF-κB Activity in Breast Cancer Cells Through IKKε and miRNA-155 Effectors.

Authors:  Jason Harquail; Nicolas LeBlanc; Carine Landry; Nicolas Crapoulet; Gilles A Robichaud
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-07-21       Impact factor: 2.673

10.  Pre-B cell receptor signaling in acute lymphoblastic leukemia.

Authors:  Rahul Nahar; Markus Müschen
Journal:  Cell Cycle       Date:  2009-12-09       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.